Atria Investments’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-19,673
Closed -$267K 876
2018
Q3
$267K Buy
19,673
+1,036
+6% +$14.1K 0.01% 817
2018
Q2
$221K Buy
+18,637
New +$221K 0.01% 860